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Abstract
Background: The majority of stroke patients are inactive outside formal therapy sessions. Tailored activity feedback
via a smartwatch has the potential to increase inpatient activity. The aim of the study was to identify the challenges
and support needed by ward staff and researchers and to examine the feasibility of conducting a randomised
controlled trial (RCT) using smartwatch activity monitors in research-naive rehabilitation wards. Objectives (Phase 1
and 2) were to report any challenges and support needed and determine the recruitment and retention rate,
completion of outcome measures, smartwatch adherence rate, (Phase 2 only) readiness to randomise, adherence to
protocol (intervention fidelity) and potential for effect.
Methods: First admission, stroke patients (onset < 4 months) aged 40–75, able to walk 10 m prior to stroke and
follow a two-stage command with sufficient cognition and vision (clinically judged) were recruited within the
Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine. Phase 1: a non-randomised
observation phase (to allow practice of protocol)—patients received no activity feedback. Phase 2: a parallel single-
blind pilot RCT. Patients were randomised into one of two groups: to receive daily activity feedback over a 9-h
period or to receive no activity feedback. EQ-5D-5L, WHODAS and RMI were conducted at baseline, discharge and
3 months post-discharge. Descriptive statistics were performed on recruitment, retention, completion and activity
counts as well as adherence to protocol.
Results: Out of 470 ward admissions, 11% were recruited across the two phases, over a 30-week period. Retention
rate at 3 months post-discharge was 48%. Twenty-two percent of patients dropped out post-baseline assessment,
78% completed baseline and discharge admissions, from which 62% were assessed 3 months post-discharge.
Smartwatch data were received from all patients. Patients were correctly randomised into each RCT group. RCT
adherence rate to wearing the smartwatch was 80%. Baseline activity was exceeded for 65% of days in the
feedback group compared to 55% of days in the no feedback group.
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Conclusions: Delivery of a smartwatch RCT is feasible in a research-naive rehabilitation ward. However, frequent
support and guidance of research-naive staff are required to ensure completeness of clinical assessment data and
protocol adherence.
Trials registration: ClinicalTrials.gov Identifier, NCT02587585–30th September 2015
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Background
Exercise has an important role in the recovery of stroke,
increasing cognition, arm function, balance and gait, in
addition to reducing the risk of subsequent cardiovascu-
lar events [1, 2]. Despite the importance of general phys-
ical activity in recovery, the majority of stroke survivors
receiving rehabilitation in hospital are inactive outside
formal therapy sessions [3, 4]. In order to encourage
long-term exercise adherence, it is recommended that
physical activity goals are customised to the individual
tolerance of the stroke patient [2].
Modern electronic activity monitors are able to provide
a wide range of behavioural monitoring tools and are
therefore emerging as a possible method to provide custo-
mised activity goals and feedback to promote exercise [5].
Coinciding with the technological developments in activity
monitoring, there is evidence to suggest that activity feed-
back of exercise may increase motivation to exercise. The
provision of activity feedback has been found to be more
effective in increasing physical activity levels than provid-
ing activity goals alone, in healthy controls [6–8] and in
older adults undergoing rehabilitation [9]. Interventions
providing feedback and monitoring of activity have shown
positive outcomes in relation to exercise adherence
amongst older individuals [10]. However, personalised ac-
tivity feedback has also found to have no effect on actual
or intended activity levels amongst controls [11]. Despite
studies suggesting a positive effect, more evidence is
needed before such activity feedback interventions can be
recommended to be used in treatment.
The literature has shown that remote monitoring of
physical activity is feasible after stroke [12]; however, the
impact of activity feedback on exercise levels within this
population is less clear. A systematic review of studies
investigating augmented feedback on motor activities
after stroke concluded that findings were inconsistent
due to the combination of multiple aspects and types of
augmented feedback used [13]. One study found that
feedback of physical activity provided three times a week
had no significant effect on the daily walking time of
stroke inpatients [14]. Little research to date has investi-
gated the use of periodic feedback of daily activity
amongst stroke patients undergoing rehabilitation. It is
of interest to see whether increasing the frequency of ac-
tivity feedback will elicit greater physical activity levels.
The provision of daily activity feedback (via a smart-
watch), relative to activity at fixed time points
through-out the previous day, may have the potential to
motivate stroke rehabilitation patients to be more active.
Conducting clinical trials within research-naive set-
tings are commonly accompanied with ethical, cultural
and organisational challenges [15]. The present study
will evaluate the feasibility of conducting the smartwatch
intervention mentioned above within a research-naive
stroke rehabilitation centre in Hefei, China (whereby no
rehabilitation research has previously been conducted).
The aim of this feasibility study was to identify the
challenges and support needed by ward staff and re-
searchers and to examine the feasibility of conducting an
RCT using smartwatch activity monitors in
research-naive rehabilitation wards. The objectives were
to report any challenges and support needed and deter-
mine the recruitment and retention rate, completion of
outcome measures, adherence to wearing the smart-
watch, readiness to randomise, adherence to protocol
(intervention fidelity) and potential for effect.
Method
Research design
The research design included two experimental phases,
an observational phase and a pilot RCT (see Fig. 1).
Criteria for participant recruitment and selection
were identical between the two phases (observation and
pilot RCT). Group allocation into either phase was de-
termined by the time from study onset. In keeping with
the allocated period of funding and to allow the max-
imum time for the pilot RCT phase, patients were re-
cruited into the observation phase 1 month from trial
onset and the pilot RCT from 2 to 6 months from trial
onset.
Phase 1: Observation phase
The observation phase was a non-randomised (non--
blinded) experimental phase. Research assessors and
ward staff were not blinded as all patients received no
activity feedback. The protocol for the observation phase
was identical to that of the pilot RCT phase, except that
there was only one group (no patients received feed-
back). Patients recruited into the observation phase were
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provided with a smartwatch that recorded their activity
but provided no feedback about the physical activity
levels during a 3-week intervention period.
Phase 2: Pilot randomised controlled trial phase
Phase two was a single-blind, pilot randomised con-
trolled trial; with the research assessor blinded to the
group allocation (it was not possible to blind the ward
staff and patients). Group allocation was performed by
an independent researcher using a 1:1 allocation ratio. A
computer-generated random sequence was generated in
Microsoft Excel to allocate groups and generate numbers
of which was then used to assign participants. The pa-
tients recruited into the pilot RCT phase were randomly
assigned using concealed allocation in envelopes held
centrally, into one of two groups:
 To receive feedback on the amount of physical
activity (movement) undertaken, two hourly for the
first 8 h and then for the last 1 to 2 hours
(dependent on the battery life) or
 To receive no feedback about the physical activity
levels during a 3-week intervention period.
Once recruited, the research office (unblinded) was in-
formed by the recruiting doctor and the research office
then registered the patient, opened the next envelope
and notified the ward (unblinded) about the patient’s
group by phone. The researcher assessors performing all
pre- and post-assessments remain blinded to group as-
signment throughout the duration of the study.
Aims and objectives
The study consisted of two phases, an initial observa-
tion phase (phase 1) and a pilot randomised con-
trolled trial (phase 2). Each phase shared the same
overall aim: to identify the challenges and support
needed by ward staff and researchers and examine
the feasibility of conducting an RCT trial using smart-
watch activity monitors in stroke survivors in
research-naive rehabilitation wards.
The objectives per phase were as follows:
 Phases 1 and 2: to report any challenges and
support needed and determine the recruitment
and retention rate, completion of outcome
measures and adherence rate to wearing the
smartwatch
 Phase 2 only: determine the readiness to randomise,
adherence to protocol (intervention fidelity) and
potential for effect.
Patients that received activity feedback (pilot RCT-
feedback group) were expected to exhibit increased
activity levels than patients who did not receive activ-
ity feedback (observation group and pilot RCT no
feedback group). It would also be expected that in-
creased activity will result in improved mobility, and
possibly cognition, arm function, independence in
daily activities and health-related quality of life within
the feedback group. However, no significant differ-
ences between groups in activity or clinical assess-
ment outcomes are expected in this trial as this is a
feasibility study and thus underpowered.
Fig. 1 Schematic representation of the research design showing two phases (observation and pilot Randomised controlled trial (pilot RCT)) and
three groups- observation, feedback and no feedback
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Research process
The study involved multiple clinical research groups
within the Second Affiliated Hospital of Anhui Univer-
sity of Traditional Chinese Medicine (ward staff (doctors
and nurses), research assessors, the Smart Watch Activ-
ity Feedback Trial Committee (SWAFT) and research
officers) and those of the Oxford Brookes Centre for
Movement, Occupational and Rehabilitation Sciences’
(MOReS) and Warwick Biomedical Engineering group.
The SWAFT team members are listed in the title page
and met weekly to resolve any local practical problems
involving the study. The ward staff conducted the smart-
watch intervention and screening of participants, and
the research assessors conducted the clinical assess-
ments and oversaw the maintenance of research data-
bases and transfer of research data.
Before this study started, the Oxford (UK) research team
visited the host hospital in Hefei twice to develop the re-
search ideas, design and governance with the local
Chinese clinical and research group. Then, specific proto-
cols (standard operating procedures) were written, ethical
applications sought in local institutional settings, and a
2-week formal training in the execution and governance
of the protocols, procedures for data collection and re-
cruitment was given to the ward staff and the research as-
sessors. The full protocol can be accessed online [16].
Specific roles within the study were as follows:
Ward staff:
 Identify and record new ward admissions
 Assess and record eligibility
 Recruit patients onto the study (recruiting doctor)
 Inform the research office of the above
 Obtain informed consent (day 0)
 Re-checking eligibility on patients who were failing
the initial clinical eligibility test (day 3)
 Initiating trial—providing smartwatch and
explaining its function (day 1)
 Preparation, distribution and collection of
smartwatches and download of data
 Checking patient after first 8 h of intervention—one
working day (day 1)
 Daily review of patients receiving intervention for
adverse events—both groups
 Inform research office of any adverse events
 Record any patient feedback
Unblinded members of the research office:
 Register new patients onto trial database
 Notify the ward about a patients group allocation
 Fortnightly teleconference calls and email data
transfer with the Oxford research team
 Receive and file consent forms
 Record ineligible patients
 Collation of data
Research assessors:
 Conduct clinical assessments and record outcome
data (in ward and via telephone at 3 months)
 Record adverse events
Oxford and Warwick research teams:
 Receiving and securing data
 Data analysis
 Technical support regarding gait sensor and
smartwatch
To monitor and provide support to increase fidelity
with the research protocol, a further visit after 3 months
was undertaken and then regular video-conferencing
calls were made every 2 weeks, and data were sent via
protected email every 2 weeks to Oxford for storage and
analysis. When required, the Warwick group provided
technical support for the smartwatch by email and
video-conferencing calls which helped to eliminate some
early issues with the smartwatch application and the way
it was being used. In these ways, as much support and
help as possible was delivered and the quality and com-
pleteness of data were monitored.
Participant selection and recruitment
Patients admitted across four rehabilitation wards in the
Second Affiliated Hospital of Anhui University of Trad-
itional Chinese Medicine, Hefei, Anhui Province, China
were recruited by a recruiting doctor that is based on
the ward. Recruitment numbers were subject to the
number of admissions to the wards within the allocated
6-month completion period of the study. All patients in-
cluded in this paper were recruited onto the study before
30th April 2016. Criteria for participant recruitment and
selection are identical between the two phases (observa-
tion and pilot RCT). Recruitment into the pilot RCT oc-
curred after the observation phase had stopped
recruiting patients.
Patients were eligible for screening if admitted after a
recent stroke (less than 4 months), and the following
questions were answered positively:
1. Can the patient follow a two-stage command,
judged clinically?
2. Was the patient walking without help from another
person before this stroke?
Recruitment was dependant on whether the patient
satisfied demographic and performance-based inclusion
criteria.
Demographic inclusion criteria are as follows:
a) are aged 40–75 years
b) are less than 4 months after stroke onset
c) are having their first admission for rehabilitation
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d) were able to walk at least 10 m prior to stroke,
without help of another person; use of equipment
allowed
Performance-based inclusion criteria are as follows:
e) have sufficient cognition to participate in study and
testing procedures (clinically judged, because there
are no valid short cognitive measures to assess
ability to consent and participate)
f ) can follow a two-stage command (e.g. pick up an
object, put it on the table)
g) has sufficient visual function to see watch feedback
(clinically judged)
h) have the capacity to consent and do give consent to
the study
If a subject matched all other inclusion criteria but was
unable to follow a two-stage command, they would be
reassessed at a 3-day follow-up and included if the criteria
were then met during this time. Only first-time admis-
sions into the stroke ward were accepted, but the stroke
could be a second or subsequent stroke provided the pa-
tient met the inclusion criteria. A member of the ward
staff responsible for recruiting explained the consent form
to eligible patients allowing ample time for full compre-
hension and to answer any questions. All patients were
given 24 h to decide if they wanted to participate in the
study. Fully informed written consent was then obtained
from willing participants in the form of a signature.
Intervention
Clinical assessments
Upon admission to rehabilitation, the standard demo-
graphic data collected on each patient as part of routine
care included age, gender, weight, height and grip strength
in the unaffected arm (left or right). Routine hospital data
were used to record total the number of patients admitted
after stroke and the dates of stroke onset. All patients re-
ceived a local routine that includes drug treatments, acu-
puncture (with additional Moxibustion, cupping and Tui
Na (Massotherapy)) and rehabilitation. The drug and acu-
puncture treatment are performed in the morning be-
tween 9:00 and 11:00 am prior to rehabilitation performed
in the afternoon and included the following:
 Drug treatment: routine neuron stimulation and
nutritional therapy (Cerebrolysin, Vinpocetine or
Ganglioside) and herb medicine for ‘promoting
blood circulation by removing blood stasis’, and
other associated symptoms or complications were
administered to all cases included in the study.
 Acupuncture treatment: acupuncture treatments
were performed according to patients’ condition
based on traditional medical diagnosis, with
additional Moxibustion, cupping or Tui Na therapy
if needed.
 Rehabilitation: Following functional evaluation of
each patient, a rehabilitation treatment plan was
established accordingly. The treatment will include
physiotherapy, occupational therapy and physical
factor therapy—including low frequency,
intermediate frequency, magnetic heat and
transcranial magnetic.
Patients with stroke within the Second Affiliated
Hospital of Anhui University of Traditional Chinese
Medicine are typically discharged from in-patient rehabili-
tation between 2 to 3 weeks, and thus the length of inter-
vention differed between subjects. All patients entered
into the research study were assessed at baseline (0 weeks)
and at discharge from the ward (≤ 3 weeks) by a research
assessor, who did not know their group allocation, on:
 Cognition, using the Montreal Cognitive Assessment
(MoCA) [17]—Mandarin version [18, 19]
 Activities of daily living, using the Barthel ADL
index [20] and the World Health Organization
Disability Assessment Scale (WHODAS) 12 item
version [21]
 Fatigue, using the Fatigue Severity Scale [22, 23] and
a visual analogue scale with anchor points of ‘no
experience of fatigue’ (= 0 mm) and ‘worst fatigue
imaginable’ (= 100 mm)
 Quality of life, using the EuroQol 5D-5L (EQ-5D-
5L) and its visual analogue scale with anchor points
of ‘best state of health you can imagine’ (100) and
‘worst state of health you can imagine’ (0) [24, 25]
 Measures of mobility; Rivermead Mobility Index
(RMI) [26] and a 10-m walk test (10MWT) time [27]
 Grip strength [28]; that provides a quantitative and
objective measure of isometric muscular strength of
the hand and forearm
 Spatio-temporal gait features at self-selected walking
speed measured during the 10MWT using an inertial
sensor on the lower trunk [29]. Participants were
instructed to walk twice along a 10-m walkway at their
normal pace with a walking aid or support of a re-
searcher.Walking speed, cadence, step length and sym-
metry of spatio-temporal measures were calculated.
Test batteries and associated instructions were
translated into Mandarin. The final assessments were
at 3 months post-discharge by telephone (one tele-
phone call was made) and included the WHODAS,
RMI and EQ-5D-5L and its visual analogue scale
only. The visual analogue scale was completed by ver-
bal instruction via telephone. The following was
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translated into Mandarin: ‘We would like to know
how good or bad your health is TODAY. On a scale
numbered from 0 to 100, where 100 means the best
health you can imagine and 0 means the worst health
you can imagine, what would you rate your health
today?’
Smartwatch activity recording
The smartwatch was instructed to be worn throughout
the day (08:00–17:00) in the rehabilitation ward from
Monday to Friday for up to 15 days (21 days elapsed in
total) or until discharge if sooner. A member of the ward
staff provided each patient with a ZGPAX S8 Android™
[30] smartwatch each morning, to wear on the un-
affected side. The watch divides elapsed time into four
periods of 2 h and one period of 1 h (to match the dur-
ation of battery life). The first day served as a baseline
measure for each time period, where none of the pa-
tients in any phase received feedback on their levels of
activity. Ward staff were instructed to explain to patients
in the feedback group that over a 2-h period, the watch
would indicate progress towards the activity goal for
those 2 h. For patients in the observation phase and the
no feedback (control) group, ward staff were required to
explain that activity scores were recorded on the watch
but otherwise provided no feedback or motivating com-
ments. Each day after baseline, the smartwatch would
automatically set the goal based on a 5% increase in the
total activity recorded in the comparable 2-h epoch the
preceding day (Friday was used for the Monday goals).
In the no feedback group, the activity level is simply re-
corded and no further processing or action occurs. The
research doctors were instructed to ask the patients
about any problems with the watch and to look out for
any observable adverse effects such as a skin rash. Each
evening at about 17:00, a member of the ward staff re-
moved the watch, downloaded the data into a computer
through a USB connection and recharged the watch
battery overnight using the same USB connector.
Encrypted smartwatch and assessment data were sent
from Anhui research office by protected email to the
Oxford research team upon completion.
The ZGPAX S8 Android™ smartwatch runs a
custom-built activity monitoring and user feedback ap-
plication established from previous work investigating
physical activity in the elderly [31, 32]. The smartwatch
specifications are shown in Additional file 1. Data from
the ZGPAX S8 tri-axial accelerometer is processed to
extract a measure of overall body movement, the activity
score, alongside an estimate of whether the watch was
or was not worn [33]. Activity score has been shown to
correlate highly (p < .001) with energy expenditure ob-
tained from whole room calorimetry [34]. The intention
of the watch is to compare relative levels of activity from
day to day rather than a specific measurement of actual
activity. A higher activity score can be achieved by either
very intense short bursts or very low intensity yet con-
tinuous movement. Activity was not summated into
standardised thresholds of passive, moderate or vigorous
exercise as this has been shown to be inappropriate for
individuals with stroke [35].
As there is little research using feedback in this manner,
no previously validated feedback icons were available. The
feedback icons used in the smartwatch software were de-
veloped in collaboration between Warwick and Oxford
Brookes with the aim of providing feedback on both activ-
ity levels and the current daily time period. Feedback was
displayed visually in the form of four progressive bars (see
Fig. 2). The bars act as an activity tracker to indicate the
amount of activity completed relative to their goal. The
bars differ in size and colour from red to green, depending
on how close the patient is to completing their activity
goal. Bar 1 is highlighted red as default, signifying little or
no activity. Bars 2, 3 and 4 correspond to completion of 1/
3 (orange), 2/3 (yellow) and 3/3 (green) of the activity goal
respectively. The clock icon shows the patient which of
Fig. 2 Activity feedback as displayed on the smartwatch screen for the feedback group (a), which included both the feedback bars and clock
face, and the no feedback (control) group (b), which included the clock face only
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the five time periods (between 08:00 and 17:00) they are
in and therefore roughly the current time. Visual presenta-
tion of the smartwatch within the control (no feedback)
group consisted of the clock icon only. Visual compari-
sons of the icons displayed by the smartwatch within the
feedback and control group are shown in Fig. 3.
Data analysis
Data analysis involved descriptive statistics performed
on recruitment, retention and completion, activity
counts as well as adherence to protocol. All data analysis
was conducted by the Oxford and Warwick research
teams. The current study is an external pilot, and there-
fore, the data collected will not form part of a subse-
quent main trial. The data collected in both phases
included the following:
 Challenges and support needed by ward staff and
researchers (office and assessors)
 Recruitment rate (percentage of patients who were
recruited out of total patients admitted for
rehabilitation after stroke)
 Retention rate (percentage of patients that
completed assessments at baseline, discharge and
follow-up out of the total number of patients
recruited)
 Duration in days between stroke event and
admission and from admission to trial registration
 Duration in days from the start of the intervention
to discharge and admission to discharge
 Range of data completion per outcome
 Process for acquiring, recording, transferring and
quality control of original trial data
 Adherence rate to wearing the smartwatch (days
the smartwatch was worn/total days of data
received)
 Adherence to protocol by research assessors and
ward staff (standard operating procedures)
 Readiness to randomise (number of patients
randomised and recorded as per the protocol)
 Potential for effect (number of days that patients
exceeded their baseline activity level per group)
 Any feedback from patients, ward staff and research
team
 Self-reported and observed adverse events (from
patients and ward staff ).
A patient’s activity was considered to have exceeded
baseline activity if the total daily activity score recorded
was greater (n > baseline) than the activity score re-
corded at baseline (day 1 of the intervention).
Ethics
This study was sponsored by the Second Affiliated Hos-
pital of Anhui University of Traditional Chinese Medicine.
The study was approved by the Chinese Ethics Committee
of Registering Clinical Trials (ChiECRCT-20150034), West
China Hospital, Sichuan University, 37 Guoxuexiang,
Chengdu, Sichuan, China. The study was registered at the
Chinese Clinical Trial Registry on 08 August 2015, num-
ber ChiCTR-IOR-15007179 and on clinical trials.gov
(NCT02587585; 30 September 2015).
All research was in compliance with the Helsinki
Declarations and the Research Governance Framework
for Health and Social Care. Informed written consent
was obtained by a recruiting doctor based on the wards,
whereby sufficient mental capacity (through clinical
judgement) and understanding of anonymity and the in-
clusion of their data was ensured by verbal confirmation.
Results
Research challenges and support needed by ward staff
and researchers
The major challenges when conducting this research in-
cluded the following:
 Maintaining consistent recording and transfer of data
 Maintaining communication between the research
and ward teams to avoid loss of participants (to
Fig. 3 Visual representation of the feedback provided on the smartwatch
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notify when patients are to be discharged and thus
require assessment)
 Ensuring clear understanding of specific roles within
the research office, assessors and ward staff
 Language barriers between the English and Chinese
teams that made it difficult to explain fine details of
data collection/transfer.
Specific support needed by the research office, re-
search assessors and ward staff included the following:
 More clarity in individual roles
 More emphasis/understanding on the importance
of complete data both from research assessors
and patients
 A bilingual individual overseeing the transfer of data
proficient in Mandarin and English to ensure full
comprehension
 Email reminders to send over the research data files
 Regular surveillance of the data collected to ensure
consistent data collection.
Recruitment and retention
Between September 22, 2015, and April 19, 2016, the
hospital admitted 470 patients for rehabilitation after
stroke and 51 (11%) were recruited into the two phases.
One patient was registered accidentally (they did not
meet the inclusion criteria of sufficient cognition), leav-
ing 50 valid patients. Patients in the observation phase
started the intervention between October 15, 2015, and
November 11, 2015. Patients in pilot RCT started the
intervention from November 11, 2015 until April 22,
2015. Demographics are shown in Table 1.
The percentage of participants retained at discharge
was 78% (39 out of 50 patients) and at 3 months
post-discharge was 48% (24 out of a total 50
patients).The last of the 3-month follow-up telephone
calls occurred on August 24, 2016. Figure 4 shows the
flow of patients in both phases of the study. Due to in-
consistent recording of excluded patients, the number of
patients that did not match each inclusion criterion is
unknown. Recruitment ended in April 2016 due to com-
pletion of the allocated funding period. Measurement
data from patients in the observation group and the pilot
RCT are shown in Tables 2 and 3 respectively.
Completeness of data
It is obvious that few patients across both phases had
complete clinical assessment data across all measures
even at discharge (see Table 4). Lost data were greater at
3 months follow-up. Eleven patients across both phases
did not receive a second assessment and 3 months
follow-up due to reduced communication between the
ward and research office. One patient in the pilot RCT
phase completed the intervention without completion of
clinical assessments at any stage. Incomplete data at
baseline (for example weight, height, 10MWT data and
grip strength) can be partly explained by patients being
unable to stand and weakness in their affected side.
Thirteen patients (five in the observation phase and
eight in the pilot RCT phase) were unable to walk.
Seven patients in the observation phase were unable
to complete the grip strength assessment due to
weakness on their left side. Detailed reasons for in-
complete baseline data for the FSS, VAF-S and WHO-
DAS were not recorded. Discharge dates were not
recorded for the majority of patients in the observa-
tion group (n = 16), although this was collected for all
RCT patients.
Despite the loss of patients, the data quality for the pa-
tients that were assessed at discharge and 3 months
post-discharge follow-up was good. Complete data were
Table 1 Patient demographics per group (mean (SD))
Observation (n = 20) Pilot RCT
Feedback (n = 14) No feedback (n = 16)
Age (years) 61 (9) 53 (12) 62 (12)
Gender (n)
Male 14 10 13
Female 6 4 3
Affected side (n)
Right 7 7 5
Left 13 7 11
Duration from Stroke event to admission (days) 74 (50) 42 (25) 50 (29)
Duration from admission to trial registration (days) 8 (7) 7 (14) 5 (10)
Duration from the start of the intervention to ward discharge (days) Unknown* 18 (7) 17 (8)
Total days from admission to ward discharge (days) Unknown* 26 (17) 22 (11)
*Due to missing discharge dates
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collected on WHODAS, MOCA, Barthel ADL Index,
RMI and EQ-5D-5L measures from all 39 patients
assessed at discharge. One patient did not cooperate on
the additional measures. Similar to baseline, seven pa-
tients could not complete the 10-m walk test at dis-
charge due to an inability to walk. At 3 months
post-discharge follow-up, the majority of patients that
were contactable completed all three assessments (RMI,
WHODAS and EQ-5D-5L measures), 21 out of 24 pa-
tients recorded.
The majority of patients in the observation phase
(see Table 4) were not recorded in the smartwatch
log leading to no record of distribution or functioning
of each smartwatch. Duplicate and mislabelled data
may be partly explained by poor understanding of the
protocol for downloading smartwatch data in the ini-
tial phase of the study, for example, how to customise
the watch with the patient ID. Smartwatch data were
consistently recorded and collated after the study pro-
gressed into the pilot RCT phase. Completeness of
smartwatch data also improved from the observation
phase to RCT. Only eight weekdays of activity data
were lost in the RCT compared to 83 weekdays in
the observation phase.
No valid gait data were recorded due to initial
problems with the functioning of the sensor (faulty
Bluetooth connection) and inconsistent recordings of
leg length and shoe size. Oxford Brookes visited the
hospital to help rectify these problems which have
now been amended to allow gait data to be recorded
for any future large-scale RCT. Activity data were
returned from all 50 patients (n = 20 observation
phase and n = 30 RCT pilot phase).
During the observation phase, duplicate data files
were common (see methods) with data files from cer-
tain days not correctly labelled with the patient iden-
tification number (ID); in response to this, the initial
process for downloading and transferring smartwatch
data was altered. Each patient’s smartwatch data were
downloaded daily (as a precaution against loss of data
in the watch), but data were not removed from the
watch until the end of the intervention. Thus, the last
Fig. 4 Participant recruitment within the observation and the pilot randomised controlled trial (RCT) phase
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download gave one complete smartwatch data file per
patient covering the whole intervention (instead of a
data file for each day of the intervention). This
allowed for easier collection and understanding of the
data when arriving in Oxford.
Adherence rate to wearing the smartwatch
Patients often forgot to wear their smartwatch, but this
problem was improved during the pilot phase by ward
staff providing regular reminders. Adherence rates for
wearing the watch (for all four periods) improved from
Table 3 Values on measures amongst participants in the pilot randomised controlled phase at each time point
Outcome Baseline 3 weeks 12 weeks/3 months
Feedback No Feedback Feedback No feedback Feedback No feedback
M (SD) Median
(range)
M (SD) Median
(range)
M (SD) Median
(range)
M (SD) Median
(range)
M (SD) Median
(range)
M (SD) Median
(range)
Performance-based
Grip strength (Kg)
Right 21 (13.2) 24 (13.1) 20 (13.7) 25 (13.6)
Left 19 (11.7) 17 (11.2) 23 (9.3) 15 (10.1)
10-m walk
test (s)
43 (31.8) 40 (32.3) 37 (34.5) 48 (41.8)
MoCA 17 (5.6) 18 (9–28) 17 (6.4) 21 (7–26) 19 (7.4) 22 (6–28) 18 (6.4) 21 (7–26)
BI 9 (4.0) 8 (5–18) 11 (4.2) 11 (5–21) 12 (3.7) 12 (6–19) 12 (4.4) 13 (7–20)
Self-report
FSS 39 (9–50) 48 (9–60) 40 (33–55) 52 (20–63)
VAF-S 6 (0–10) 8 (0–10) 5 (3–10) 7 (5–10)
EQ-5D-5L VAS 47.9 (24.9) 52 (10–90) 55 (29.6) 60 (0–100) 52 (24.5) 57 (0–80) 61 (26.0) 70 (20–100) 55 (24.2) 50 (30–90) 60 (10.2) 60 (50–75)
RMI 4 (1–13) 6 (2–15) 8 (1–14) 6 (3–15) 8 (3–15) 9 (0–14)
WHODAS 48 (12–85) 54 (16–87) 46 (4–79) 44 (20–95) 39 (2–60) 45 (4–79)
Data were included only if the patient successfully completed assessment.
Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue
Scale;
EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health
Organization Disability Assessment Schedule (12-item); M, mean; SD, standard deviation. WHODAS scores represent a percentage of the maximum
disability score (the total score, between 0 and 48, is divided by 48 and multiplied by 100)
Table 2 Values on measures amongst participants in the observation phase at each time point
Outcome Baseline 3 weeks 12 weeks/3 months
M (SD) Median (range) M (SD) Median (range) M (SD) Median (range)
Performance-based
Grip strength (Kg)
Right 17 (12.4) 18 (13.7)
Left 14 (11.4) 12 (12.3)
10-m walk test (s) 41 (28.4) 52 (52.7)
MoCA 14 (6.2) 13 (4–26) 17 (4.8) 18 (7–25)
BI 11 (4.5) 10 (4–20) 11 (3.5) 11 (6–17)
Self-report
FSS 43 (15–63) 51 (11–61)
VAF-S 6 (0–10) 7 (2–10)
EQ-5D-5L VAS 57 (26.2) 60 (10–100) 59 (26.8) 65 (0–100) 56 (16.5) 60 (30–85)
RMI 6 (1–14) 8 (1–12) 9 (0–15)
WHODAS 45 (18–83) 53 (33–77) 44 (12–100)
Data were included only if the patient successfully completed assessment.
Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale;
EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization
Disability Assessment Schedule (12-item). M (SD), mean and standard deviation. WHODAS scores represent a percentage of the maximum disability score (the
total score, between 0 and 48, is divided by 48 and multiplied by 100)
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14% during the observation phase to that of 74% in the
feedback and 86% in the no feedback group. Patient ad-
herence to wearing the watch is summarised in Table 5.
Adherence to protocol
Ward staff actively took part in both phases of the study
despite no financial reward. Overall, in both phases, re-
cruitment adhered to the inclusion criteria, apart from
age, whereby individuals under the age of 45 and over
the age of 75 were recruited, and stroke onset, whereby
five patients in the observation phase and one in the
feedback group were recruited with a stroke onset of
more than 4 months. In addition, grip strength in both
the unaffected and affected arm was measured.
In addition to weekdays, activity was also recorded on
weekends leading to an increase in data than originally
expected. The total number of days of activity data re-
corded per group, including and excluding weekends, is
summarised in Table 4. The range of intervention length
was greatest in the observation group (5–45 days) but
matched between the feedback (2–29 days) and the no
feedback group (3–23). The length of stay in the
observation group was estimated from the smartwatch
data as minimal discharge dates were given.
During the pilot RCT phase, patients were randomised
into the feedback or no feedback group effectively. How-
ever, during the 3-month observation visit (see
methods), it was apparent that the functioning and feed-
back system of the smartwatch was not consistently ex-
plained to patients. It is therefore possible that patients
within the feedback group will not have fully understood
or been aware of the function of their smartwatch in re-
lation to their activity.
Readiness to randomise
All patients in the pilot RCT phase were correctly rando-
mised into each group (see Fig. 4) and provided with the
correct smartwatch (that provides feedback or does not
provide feedback) as validated in the smartwatch log.
Potential for effect
Only activity recorded during time periods of 1 to 4
(representing the time period between 08:00–16:00)
were included in analysis due to the limited battery life
Table 4 Completion rates of measures amongst participants in the observation and pilot randomised controlled trial phase
Completion Observational
phase (n = 20)
Pilot RCT Phase (n = 30)
Feedback (n = 14) No feedback (n = 16)
Full (100%) Completion
range
Full (100%) Completion
range
Full (100%) Completion
range
Performance-based outcomes (n = 5)*
Baseline n = 3 n = 2 65–75% n = 2 n = 3 57–78% n = 0 n = 5 75–93%
3 weeks n = 0 n = 5 55–70% n = 0 n = 5 50–85% n = 0 n = 5 62–75%
12 weeks
Self-report outcomes (n = 5)^
Baseline n = 2 n = 3 90–95% n = 2 n = 3 85–92% n = 0 n = 5 87–93%
3 weeks n = 0 n = 5 65–70% n = 0 n = 5 78–85% n = 0 n = 5 75%
12 weeks (n = 3) n = 0 n = 3 35–45% n = 0 n = 3 42–50% n = 0 n = 3 50%
Smartwatch activity data
Patient data recorded by watch and downloaded by ward staff n = 20 100% n = 14 100% n = 16 100%
Smartwatch data recorded in log n = 4 20% n = 14 100% n = 16 100%
Completion range refers to the percentage of recruited patients whom successfully completed assessment across measures
*Grip strength left, grip strength right, 10-m walk test; MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index
^FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale);
RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item)
Table 5 Patient adherence to wearing the smartwatch monitor
Trial Daysa Periods worn for in days (percentage)b
4 (All periods) 3 2 1 ≥ 1
Observation 450 (328) 49 (14.9%) 145 (44.2%) 34 (10%) 17 (5.2%) 245 (74.7%)
Pilot RCT-feedback 240 (175) 131 (74.4%) 38 (21.6%) 6 (3.4%) 1 (0.6%) 176 (100.6%)
Pilot RCT-no feedback 216 (152) 131 (86.2%) 23 (15.1%) 4 (2.6%) 1 (0.7%) 159 (104.6%)
aTotal days (weekdays). bdays worn divided by weekdays; multiplied by 100 to get percentage
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and thus variance in duration of time period 5. When
comparing daily activity levels, the feedback group were
more active on average; however, there was more vari-
ability in the control (no feedback) group at baseline (see
Table 6). A summary of activity levels per group per
time point is shown in Table 7 (and visually in Fig. 5).
Analysis metrics of activity scores across the intervention
for an individual patient within the control and feedback
group are shown in Figs. 6 and 7 retrospectively.
The results from the smartwatch activity data are clearly
very preliminary and show that it is feasible to obtain the
data, but due to the high inter-personal variability (as would
be expected), these results do not show any differences and
therefore any further statistical analysis would be misleading
at this stage. Due to an incomplete and extremely variable
dataset (see Fig. 5 and Additional file 2), no further statis-
tical analyses were conducted as the data is underpowered.
The shortcomings and issues reported in the discussion
which resulted in this dataset can be addressed; after
which, a full study would be able to answer the clinical
questions with a significant expansion in sample size.
No feedback was reported by the ward staff or re-
search team despite prompts. One participant refused to
wear the watch; however, no adverse effects or side ef-
fects of wearing the watch were reported.
Discussion
This pilot study identified the challenges and support
needed by ward staff and researchers and examined the
feasibility of conducting an RCT using smartwatch activ-
ity monitors in research-naive rehabilitation wards. The
main challenges when conducting this research were ac-
quiring research data on a consistent sustainable basis,
maintaining effective communication between the re-
search and ward teams, ensuring clear understanding of
roles and language barriers between the Chinese and UK
teams. Frequent support was required in the form of
email reminders to transfer assessment data, fortnightly
teleconference calls and regular surveillance of incoming
data. Delivery of a smartwatch RCT is feasible in a
research-naive rehabilitation ward (in terms of recruit-
ment rate, retention, adherence to wearing the watch,
readiness to randomise and potential for effect); how-
ever, frequent support and guidance of research-naive
staffs are required to ensure completeness of clinical as-
sessment data and protocol adherence (specifically watch
instructions). Recommendations for a follow-on RCT in-
clude an increase in the number of wards to aid recruit-
ment, increasing the number of attempts to conduct
3 months post-discharge follow-up, weekly surveillance
of incoming data to ensure data quality and the addition
of a UK-based bilingual (English and Mandarin) research
member to aid communication.
As in a number of trials, we found that although there
are many patients admitted to the busy general hospital
for stroke rehabilitation and despite the simple broad re-
cruitment criteria, it proved difficult to recruit many pa-
tients. Retention rates were adequate at discharge
despite the lost patients; however, telephone follow-up
rates were low. Despite these difficulties, the ward staff
did participate actively in recruitment and in delivery of
the intervention undertaken as part of their daily work
(they were not employed as or paid for being re-
searchers), and over time, the quality of data improved.
Patients exhibited high adherence to wearing the smart-
watch, and activity data were collected and transferred
effectively. On average, patients that received feedback
did exceed their baseline activity level on more days than
those that did not receive feedback, indicating a poten-
tial for effect.
Table 6 Activity recorded per group in comparison to baseline
Collected data daysa Number of days that activity exceeded baseline Rate of increased activity (%)b
Observation 328 (245) 207 63.1 (84.5)
Pilot RCT-feedback 175 (176) 115 65.7 (65.3)
Pilot RCT-no feedback 152 (159) 87 57.2 (54.7)
aExpected (actual). Expected day refers to the total number of weekdays from when a patient started the trial and when they left the trial. This is then summed
over the group. Actual refers to the actual number of weekdays that data were collected
bTotal number of days that activity levels exceeded baseline divided by total expected and actual (in brackets) days; multiplied by 100 to get percentage
Table 7 Activity score across the intervention per experimental phase (median < quartile 2–quartile 3 > [N])
Observation Pilot RCT
Feedback No feedback
Baseline 79 < 0–118 > [20] 172 < 144–200 > [14] 150.5 < 75–201 > [16]
Day 5 0 < 0–96 > [17] 136 < 0–182.5 > [11] 119 < 0–168.25 > [15]
Day 10 107 < 67.5–176.75 > [17] 0 < 0–193 > [10] 95 < 0–159 > [12]
Day 15 93 < 14.5–182.75 > [15] 163.5 < 131–209 > [10] 101.5 < 97–151 > [6]
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Assessment data at baseline were well executed with
minimal data loss, but completeness of data was much
less at discharge or at the end of the intervention due to
lost patients. The research staffs were capable of con-
ducting the clinical assessments to a good standard;
however, difficulties were shown in the recording and
transferring of the data itself. The majority of missing
data from the second assessment can be accounted for
by patients being discharged from the ward before as-
sessments could take place or without the research team
being notified. Practice of procedures during the obser-
vation phase of the study alongside the simplicity of the
protocol will have helped maintain data loss. The obser-
vation phase also allowed time to solve or highlight un-
foreseen problems prior to the RCT (e.g. the specific
method of how to download smartwatch data and errors
with the Bluetooth on the gait sensor). Despite this, a
greater emphasis on the importance of collecting all re-
quired data and full comprehension of the patient on
their role in the study could discourage such gaps in
data. A better system of notifying research staff of
planned and actual discharges should help. The presence
of a qualified and experienced member of staff with re-
sponsibility for ensuring the collection of all assessments
would better support data collection fidelity.
The outcome measures utilised could feasibly be imple-
mented in the research setting in follow on studies as de-
tailed below. Compliance to collecting the smartwatch data
and wearing the watch was high, suggesting that it is a
feasible method to record patient activity. There were
missing data on outcome measures; however, this was
mostly due to lost patients from poor communication ra-
ther than the ability to complete/conduct the assessments.
Complete measures of cognition, independence in
daily activities and health-related quality of life were
collected for all of the 39 patients that were assessed
at discharge. Some loss in arm function (grip
strength) and mobility (10MWT) data were due to
weakness or an inability to walk. Despite missing walk
data, the other measure of mobility, Rivermead
Mobility Index, had complete recorded data for all
patients assessed at baseline, discharge and 3 months
post-discharge follow-up, indicating that it is feasible
to calculate mobility in a follow-on trial using this
measure if the problem of lost patients is resolved. At
3 months post-discharge follow-up, the majority of
patients that were contactable completed all three as-
sessments (RMI, WHODAS and EQ-5D-5L measures).
Therefore, the measures used seem to be appropriate
for the aims of the study, and rather, the issue that
needs to be addressed for a follow-on main trial is
the likelihood of contact at the 3-month follow-up ra-
ther than suitability of measures.
The follow-up at 3 months had to be by (mobile) tele-
phone, because patients do not routinely attend an
out-patient clinic and to travel back specially would not
be easy, especially as costs could not be reimbursed.
This explains the lower rate of data collection. However,
with better planning such as:
 Specifically mentioning the fact of a phone call at
discharge, with a written note and verbally to
patient and family
 Sending a reminder text 1 week beforehand, also
offering a number to phone
 Allowing three attempts to make contact
Fig. 5 Box plots showing the variance of activity score amongst participants in the observation (O), feedback (F) and no feedback (NF) group
across 15 weekdays. + Crosses indicate outliers
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it might be possible to acquire more data. Other means in-
clude online forms; post is not sufficiently reliable to be
an option. To encourage larger follow-up rates, these
changes are recommended for any future large-scale RCT.
To achieve minimal loss of data, a greater emphasis
on the importance of feedback between the ward staff
and the research assessors about patient progress
through the trial, protocol deviation and the effective-
ness of data collection procedures is recommended. For
example, uploading the assessment and smartwatch data
collected in China onto a secure, interactive online web
space that could be assessed daily by the UK team would
allow the data to be checked as it is updated in
real-time. Previous multi-centre research has used inter-
active platforms allowing access to up-to-date data, as
well as information regarding design, consent and
verification of trial events to reduce the time taken to
identify and resolve data-related queries and errors [36].
The lack of collected data regarding recruitment num-
bers and specifically the numbers of patients that did
not match the inclusion criteria is a major limitation of
this study. Patients in the study were confirmed to have
met the eligibility criteria as recorded in the data collec-
tion forms; however, no information was recorded on
the number of patients that were ineligible and the rea-
sons why. The current study has therefore not informed
a follow-on main trial on the reason behind the
low-recruitment numbers, and thus the potential of re-
cruitment bias cannot be assessed. An additional limita-
tion of the study was that any occurrences of research
assessors becoming unblinded to the patients group (be
it feedback or no feedback) were not recorded, and
(a) (b)
(c) (d)
Fig. 6 Graphs showing different analysis metrics of activity score (AS) from participant 1033 (Pilot RCT-No Feedback Group). Graphs (a) and (b)
show the difference in AS from baseline AS (BAS). Graphs (c) and (d) show the difference in AS from the previous day’s values. P1 to P4 refer to
each 2-h time period between 08:00 and 16:00
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therefore it is unknown whether this unblinding could
have biased the clinical assessments. For a follow-on
trial, the importance of the eligibility/screening log
should be reinforced to all staff involved in the study
and also during each fortnightly teleconference call.
Effective communication between the Chinese re-
search team and the Chinese ward teams on the one
hand and the English research teams (Oxford Brookes
and Warwick) on the other hand were one of the main
challenges within this study. As an international study,
the challenges included language barriers, time differ-
ences which affected scheduling of Skype meetings and
practical difficulties as direct face-to-face research input
and explanation was not possible at short notice or on a
regular basis. Nonetheless, regular Skype meetings were
effective in raising concerns and queries, although time
consuming due to the need for frequent translations. For
a follow-on trial, a bilingual (English and Mandarin) re-
search member is advised to aid comprehension during
the meetings and during data transfer.
The ward staff initially did not adhere to the protocol
concerning the smartwatch. During an observation visit
by the UK teams, ward staff provided smartwatches to
each group but they did not consistently explain the
function and purpose of the watch. One reason may be
that daily schedules of ward staff and time restraints
meant that many staff were involved, often not really
knowing what to do. The communication of complex re-
search protocols across languages may have led to lack
of clarity in the implementation of procedures. Despite
this, smartwatch data were collected to a high standard
with data collected from all patients.
One consideration when evaluating this intervention is
the possible impact of the Hawthorne effect (also
Fig. 7 Graphs showing different analysis metrics of activity score (AS) from participant 1029 (Pilot RCT-Feedback Group). Graphs (a) and (b) show
the difference in AS from baseline AS (BAS). Graphs (c) and (d) show the difference in AS from the previous day’s values. P1 to P4 refer to each 2-h
time period between 08:00 and 16:00
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referred to as observer effects); the alteration of a partic-
ipant’s behaviour caused by their awareness of being ob-
served (for a review see [37]). All patients are likely to
have exhibited increased levels of activity than if they
were not provided with smartwatches monitoring their
activity, regardless of whether feedback was provided.
The aim of the smartwatch is to evoke a change in be-
haviour, specifically an increase in movement, due to the
monitoring and provision of activity feedback. Therefore,
any observer effects are expected and can be seen as a
result of the research design rather than a bias that
would hinder the effectiveness of the intervention. As
monitoring and thus possible observation effects oc-
curred in both experimental groups, the impact of feed-
back specifically can still be determined by comparing
the feedback and no feedback groups. However, it ap-
peared that the ward staff did not appear to consistently
explain the monitoring system of the smartwatch to pa-
tients which may have led to a different understanding
of the purpose of the smartwatch and thus different ob-
server effects between patients and/or groups.
The lack of an independent measure to monitor
whether the watch was worn was a major limitation of
the model of smartwatch used. The smartwatch pro-
duces only an arbitrary measure of whether the watch
was being worn; using an algorithm based on movement
and probably underestimates the time worn, for ex-
ample, if the patient was lying quietly in bed. The
addition of a temperature sensor or pulse rate monitor
could overcome this, increasing the validity of the activ-
ity measure. In addition, the smartwatch only produces
processed data, due to its limited storage capacity. A lar-
ger storage capacity would allow direct access to raw ac-
tivity data after its collection, and thus open wider
opportunities of data analysis, for example, producing
movement graphs [31].
The time-frame with which the activity is recorded
(08:00–17:00) may also bias the activity levels re-
corded. The local ward routine alongside medical
and rehabilitation schedules limits the time available
for patients to alter their activity levels. Indeed, it is
precisely the evenings and weekends that offer the
biggest opportunities for increased patient activity. A
smartwatch with a battery life able to record from
morning to night and over 2 or 3 days would provide
a richer account of activity changes and much more
likelihood of targeted feedback altering behaviour.
One possibility to increase the amount of activity re-
corded is for patients to wear and charge their own
smartwatch over the weekend. Future research would
need to investigate whether charging of the smart-
watch by patients is feasible, for example, in terms of
data loss, protocol compliance and maintaining ran-
domisation of groups.
Whilst the authors recognise that the smartwatch does
have some shortcomings, it must be noted that it is the
best device for meeting the requirements of the project,
when compared to commercial activity monitors or
paired-to-smartphone smartwatches. That is, that it pro-
vides the sensing capacity, on-board processing, and user
interaction capabilities to monitor and provide real-time
feedback as a single standalone device. These capabilities
are not otherwise available, and if the limitations were
overcome, the smartwatch performance would be greatly
enhanced. The use of accelerometers as a measurement
of activity within stroke patients is a widely used
method, generating valid and reliable insights into activ-
ity levels [38–40]. Nevertheless, it has yet to be shown
that feedback from accelerometers leads to actual
long-term change in behaviour amongst this population.
Despite the reported difficulties in data collection and
recruitment, conducting clinical trials within developing/
research-naive settings, such as many hospitals in China,
is becoming more prevalent. In comparison to Europe
and North America, research in developing countries
offer smaller running costs and large numbers of pa-
tients, often due to higher rates of disease as well as lar-
ger populations, allowing for large scale clinical trials
[41]. Conducting the present trial within Anhui hospital
in China did indeed provide a large pool of stroke pa-
tients from which to recruit, but final recruitment num-
bers were in comparison small. An increase in the
number of recruitment wards (eight wards in total) is
recommended for a follow-on RCT.
In order to emphasise and maintain the importance of
strong adherence to protocol, future studies conducting
similar research within a research-naive setting are ad-
vised to provide frequent support and training by experi-
enced and qualified researchers alongside separate
experimental phases to determine the feasibility of as-
sessment and randomisation. An observation phase prior
to randomisation allows a period to implement mea-
sures, increasing understanding and sound practice of
protocol procedures to better prepare and maintain a
high-quality randomised intervention. Additional con-
siderations from this research include the selection of a
smartwatch that meets the functional requirements of
the project whilst possessing a maximum battery life that
complements the duration of data collected, and data
that can be checked and assessed as it is being collected
by both research teams in order to maintain data quality.
Adjustments required for a follow-on RCT include in-
creasing the number of wards to aid recruitment, in-
creasing the number of attempts to conduct the
3 months post-discharge follow-up, weekly surveillance
of incoming data to ensure data quality and the addition
of a UK-based bilingual (English and Mandarin) research
member to aid communication.
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Conclusion
Activity levels of stroke survivors undergoing rehabilita-
tion are commonly below the recommended levels for
optimal recovery. Tailored feedback of physical activity
is a possible method to encourage greater levels of activ-
ity and thus positive clinical outcomes post-stroke. The
aim of this feasibility study was to identify the challenges
and support needed by ward staff and researchers and to
examine the feasibility of conducting an RCT using
smartwatch activity monitors in research-naive rehabili-
tation wards. Delivery of a smartwatch RCT is feasible in
a research-naive rehabilitation ward; however, frequent
support and guidance of research-naive staff is required
to ensure completeness of clinical assessment data and
protocol adherence. Adjustments required for a
follow-up RCT include increasing the number of wards
to aid recruitment, increasing the number of attempts to
conduct 3 months post-discharge follow-up, weekly sur-
veillance of incoming data to ensure data quality and the
addition of a UK-based bilingual (English and Mandarin)
research member to aid communication.
Additional files
Additional file 1: ZGPAX S8 Android Smartwatch Specifications.
(DOCX 12 kb)
Additional file 2: Distribution plots showing distribution of total daily
activity scores for Feedback group (A), No Feedback (control) group (B),
observation group (C) and all groups (D). Table 7 shows a summary of
this data at days 1, 5, 10 and 15. Red crosses indicate the mean and
green squares the median. (DOCX 96 kb)
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